Moderna, Inc. (MRNA)
Nasdaq: MRNA · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2016
Who owns Moderna, Inc.
As filed with the SECHolders of 5% or more
3
Fmr LLC holds 13.1% of COMMON STOCK, as its SCHEDULE 13G/A filed Aug 6, 2026 says.
Directors and officers
14
report now, of 31 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · COMMON STOCK · 10.6% in Feb 6, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Capital World Investors
SCHEDULE 13G · filed Aug 12, 2026 · Common Stock
Baillie Gifford & Co
SCHEDULE 13G/A · filed Jul 24, 2026 · Common Stock · reported falling below 5%, from 5.3% in Feb 9, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What MRNA reports owning in othersstakes of 5% or more, and other ties
29 subsidiaries in 18 countries, from the list filed with the 10-K filed Feb 20, 2026.
Insider tradesForm 4
22sales
0purchases
20sales on a scheduled plan
6people selling
$81.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 9, 2025 to Nov 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 36 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Hoge Stephen | President | 9 | $45.4M | 9 | 0 | $0 |
| Bancel Stephane | Chief Executive Officer | 4 | $28.7M | 4 | 0 | $0 |
| Mock James M | Chief Financial Officer | 2 | $4.7M | 2 | 0 | $0 |
| Klinger Shannon Thyme | Chief Legal Officer | 3 | $1.4M | 3 | 0 | $0 |
| Afeyan Noubar | director | 2 | $1.1M | 0 | 0 | $0 |
| Hussain Abbas | director | 2 | $300,000 | 2 | 0 | $0 |